AtaCor Medical Revenue and Competitors

San Clemente, CA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AtaCor Medical's estimated annual revenue is currently $6.8M per year.(i)
  • AtaCor Medical's estimated revenue per employee is $271,080

Employee Data

  • AtaCor Medical has 25 Employees.(i)
  • AtaCor Medical grew their employee count by 9% last year.

AtaCor Medical's People

NameTitleEmail/Phone
1
Co-Founder & VP Clinical, Regulatory & QualityReveal Email/Phone
2
General Counsel, CFOReveal Email/Phone
3
General Counsel & CFOReveal Email/Phone
4
CEO & Co-FounderReveal Email/Phone
5
Director Field Clinical EngineersReveal Email/Phone
6
Director, Quality SystemsReveal Email/Phone
7
Director Regulatory AffairsReveal Email/Phone
8
Office ManagerReveal Email/Phone
9
Sr. Clinical Research Project ManagerReveal Email/Phone
10
Sr. R&D EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M7920%N/AN/A
#2
$8.5M3111%N/AN/A
#3
$4.5M13-13%N/AN/A
#4
$8M25-4%N/AN/A
#5
$5.3M16-6%N/AN/A
#6
$54.2M163-8%N/AN/A
#7
$12M55-17%N/AN/A
#8
$10M30-9%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M43-7%N/AN/A
Add Company

What Is AtaCor Medical?

At AtaCor Medical, we envision a new world of cardiac rhythm management. As a result, we are designing innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most. Representing the future of temporary pacing without the risks, costs, and drawbacks of traditional methods, the AtaCor EV Temporary Pacing System is designed to: - Enable reliable, prompt, imaging-free temporary pacing with safe post-procedure ambulation - Eliminate the complications associated with transvenous leads - Eliminate the patient discomfort of transcutaneous pacing The AtaCor EV Temporary Pacing System is under development and not approved for sale in any geography.

keywords:N/A

N/A

Total Funding

25

Number of Employees

$6.8M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AtaCor Medical News

2022-04-13 - Pulsed Field Ablation Treats AF With Few Complications

New medical technology raises important questions of efficacy and ... Ablacon, Acutus Medical, Affera, Apama Medical, Aquaheart, Atacor,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M25178%N/A
#2
$5.6M25-14%N/A
#3
$2.2M2653%N/A
#4
$2.3M2723%N/A
#5
$3.9M270%N/A